Cargando…
Efficacy of low-protein diet for diabetic nephropathy: a systematic review of randomized controlled trials
BACKGROUND: A low-protein diet (LPD) is believed to be beneficial in slowing the progression of kidney disease. It is reported that low protein diet can improve protein, sugar and lipid metabolism, and reduce the symptoms and complications of renal insufficiency. However, there has been controversia...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006775/ https://www.ncbi.nlm.nih.gov/pubmed/29914534 http://dx.doi.org/10.1186/s12944-018-0791-8 |
_version_ | 1783332906671800320 |
---|---|
author | Zhu, Huan-gao Jiang, Zhao-shun Gong, Pi-yun Zhang, Dong-mei Zou, Zhi-wei Qian-Zhang Ma, Hui-mei Guo, Zhen-gang Zhao, Jun-yu Dong, Jian-jun Lin-Liao |
author_facet | Zhu, Huan-gao Jiang, Zhao-shun Gong, Pi-yun Zhang, Dong-mei Zou, Zhi-wei Qian-Zhang Ma, Hui-mei Guo, Zhen-gang Zhao, Jun-yu Dong, Jian-jun Lin-Liao |
author_sort | Zhu, Huan-gao |
collection | PubMed |
description | BACKGROUND: A low-protein diet (LPD) is believed to be beneficial in slowing the progression of kidney disease. It is reported that low protein diet can improve protein, sugar and lipid metabolism, and reduce the symptoms and complications of renal insufficiency. However, there has been controversial regarding the effects of protein restriction on diabetic nephropathy (DN). OBJECTIVE: To investigate the efficacy of LPD on renal function in patients with type 1 or 2 DN by meta-analysis of randomized controlled trials (RCTs). DESIGN: PubMed, MEDLINE, EMBASE and China National Knowledge Infrastructure databases were searched. Eleven randomized controlled trials met the inclusion criteria, of which 10 were English and 1 was Chinese. The primary outcome was a change in glomerular filtration rate (GFR). The secondary outcome was a change in proteinuria. Random-effects models were used to calculate the standardized mean difference (SMD) and the corresponding 95% confidence intervals (CI). Subgroup analyses were also performed. RESULTS: Our research indicated that LPD was not associated with a significant improvement in GFR (1.59 ml · min(−1) · 1.73 m(−2), 95% CI -0.57, 3.75, I(2) = 76%; p = 0.15). This effect was consistent across the subgroups regardless of type of diabetes, course of diabetes and intervention period. Our results also showed that there was no significant difference on improvement of proteinuria in patients of LPD and those in normal-protein diet groups (− 0.48, 95%CI-1.70, 0.74, I(2) = 94%, p = 0.44). Subgroup analysis revealed that LPD resulted in increased excretion of proteinuria in patients with type 2 diabetes (1.32, 95% CI 0.17, 2.47, I(2) = 86%, p = 0.02). CONCLUSION: The present research showed that LPD was not significantly associated with improvement of renal function in patients with either type 1 or 2 diabetic nephropathy. Although these results do not completely eliminate the possibility that LPD is beneficial for patients with diabetic nephropathy, it does not seem to be significant benefit to renal function. |
format | Online Article Text |
id | pubmed-6006775 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60067752018-06-26 Efficacy of low-protein diet for diabetic nephropathy: a systematic review of randomized controlled trials Zhu, Huan-gao Jiang, Zhao-shun Gong, Pi-yun Zhang, Dong-mei Zou, Zhi-wei Qian-Zhang Ma, Hui-mei Guo, Zhen-gang Zhao, Jun-yu Dong, Jian-jun Lin-Liao Lipids Health Dis Research BACKGROUND: A low-protein diet (LPD) is believed to be beneficial in slowing the progression of kidney disease. It is reported that low protein diet can improve protein, sugar and lipid metabolism, and reduce the symptoms and complications of renal insufficiency. However, there has been controversial regarding the effects of protein restriction on diabetic nephropathy (DN). OBJECTIVE: To investigate the efficacy of LPD on renal function in patients with type 1 or 2 DN by meta-analysis of randomized controlled trials (RCTs). DESIGN: PubMed, MEDLINE, EMBASE and China National Knowledge Infrastructure databases were searched. Eleven randomized controlled trials met the inclusion criteria, of which 10 were English and 1 was Chinese. The primary outcome was a change in glomerular filtration rate (GFR). The secondary outcome was a change in proteinuria. Random-effects models were used to calculate the standardized mean difference (SMD) and the corresponding 95% confidence intervals (CI). Subgroup analyses were also performed. RESULTS: Our research indicated that LPD was not associated with a significant improvement in GFR (1.59 ml · min(−1) · 1.73 m(−2), 95% CI -0.57, 3.75, I(2) = 76%; p = 0.15). This effect was consistent across the subgroups regardless of type of diabetes, course of diabetes and intervention period. Our results also showed that there was no significant difference on improvement of proteinuria in patients of LPD and those in normal-protein diet groups (− 0.48, 95%CI-1.70, 0.74, I(2) = 94%, p = 0.44). Subgroup analysis revealed that LPD resulted in increased excretion of proteinuria in patients with type 2 diabetes (1.32, 95% CI 0.17, 2.47, I(2) = 86%, p = 0.02). CONCLUSION: The present research showed that LPD was not significantly associated with improvement of renal function in patients with either type 1 or 2 diabetic nephropathy. Although these results do not completely eliminate the possibility that LPD is beneficial for patients with diabetic nephropathy, it does not seem to be significant benefit to renal function. BioMed Central 2018-06-19 /pmc/articles/PMC6006775/ /pubmed/29914534 http://dx.doi.org/10.1186/s12944-018-0791-8 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zhu, Huan-gao Jiang, Zhao-shun Gong, Pi-yun Zhang, Dong-mei Zou, Zhi-wei Qian-Zhang Ma, Hui-mei Guo, Zhen-gang Zhao, Jun-yu Dong, Jian-jun Lin-Liao Efficacy of low-protein diet for diabetic nephropathy: a systematic review of randomized controlled trials |
title | Efficacy of low-protein diet for diabetic nephropathy: a systematic review of randomized controlled trials |
title_full | Efficacy of low-protein diet for diabetic nephropathy: a systematic review of randomized controlled trials |
title_fullStr | Efficacy of low-protein diet for diabetic nephropathy: a systematic review of randomized controlled trials |
title_full_unstemmed | Efficacy of low-protein diet for diabetic nephropathy: a systematic review of randomized controlled trials |
title_short | Efficacy of low-protein diet for diabetic nephropathy: a systematic review of randomized controlled trials |
title_sort | efficacy of low-protein diet for diabetic nephropathy: a systematic review of randomized controlled trials |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006775/ https://www.ncbi.nlm.nih.gov/pubmed/29914534 http://dx.doi.org/10.1186/s12944-018-0791-8 |
work_keys_str_mv | AT zhuhuangao efficacyoflowproteindietfordiabeticnephropathyasystematicreviewofrandomizedcontrolledtrials AT jiangzhaoshun efficacyoflowproteindietfordiabeticnephropathyasystematicreviewofrandomizedcontrolledtrials AT gongpiyun efficacyoflowproteindietfordiabeticnephropathyasystematicreviewofrandomizedcontrolledtrials AT zhangdongmei efficacyoflowproteindietfordiabeticnephropathyasystematicreviewofrandomizedcontrolledtrials AT zouzhiwei efficacyoflowproteindietfordiabeticnephropathyasystematicreviewofrandomizedcontrolledtrials AT qianzhang efficacyoflowproteindietfordiabeticnephropathyasystematicreviewofrandomizedcontrolledtrials AT mahuimei efficacyoflowproteindietfordiabeticnephropathyasystematicreviewofrandomizedcontrolledtrials AT guozhengang efficacyoflowproteindietfordiabeticnephropathyasystematicreviewofrandomizedcontrolledtrials AT zhaojunyu efficacyoflowproteindietfordiabeticnephropathyasystematicreviewofrandomizedcontrolledtrials AT dongjianjun efficacyoflowproteindietfordiabeticnephropathyasystematicreviewofrandomizedcontrolledtrials AT linliao efficacyoflowproteindietfordiabeticnephropathyasystematicreviewofrandomizedcontrolledtrials |